Ideal switch over therapy from intravenous Ceftriaxone in serious RTIs.

Proven efficacy in acute Otitis Media, Tonsillitis and Pharyngitis.

Clinical cure rate : 90.3% in Pharyngotonsillitis.

Drug of Choice in Treatment of most URTIs.

Pneumonia

Acute Uncomplicated Urethritis

Cervical & Anorectal gonorrhea

Uncomplicated GI Tract Infection

Lower & Upper Respiratory Tract Infection